LivaNova (LIVN) Net Income towards Common Stockholders (2014 - 2026)
LivaNova's (LIVN) quarterly Net Income towards Common Stockholders came in at $23.1 million in Q1 2026, up 107.07% year-on-year from $11.2 million in Q1 2025, and down 25.14% quarter-over-quarter from $30.9 million in Q4 2025.
LivaNova (LIVN) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
LivaNova has disclosed Net Income towards Common Stockholders across 12 years of filings, most recently posting $23.1 million for Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at $23.1 million, up 107.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $108.0 million (up 148.63% YoY), and the FY2025 annual result was -$242.4 million, down 483.26% from the prior year.
- Net Income towards Common Stockholders came in at $23.1 million for Q1 2026 at LivaNova, down from $30.9 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $55.9 million in Q4 2024 to a low of -$327.3 million in Q1 2025.
- The 5-year median for Net Income towards Common Stockholders is $16.4 million (2023), against an average of -$13.2 million.
- Across the five-year window, Net Income towards Common Stockholders surged 1283.09% in 2024 and slumped 680.83% in 2025, its largest moves.
- LivaNova's Net Income towards Common Stockholders stood at $1.7 million in 2022, then surged by 867.81% to $16.4 million in 2023, then surged by 241.72% to $55.9 million in 2024, then sank by 44.69% to $30.9 million in 2025, then fell by 25.14% to $23.1 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $23.1 million (Q1 2026), $30.9 million (Q4 2025), and $26.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | LivaNova | 4.34 Bn | 3.76 Bn | 243.75 Mn | 23.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.15 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 27.17 Mn |
| Mar 31, 2025 | -327.30 Mn |
| Dec 31, 2024 | 55.89 Mn |
| Sep 30, 2024 | 32.92 Mn |
| Jun 30, 2024 | 16.36 Mn |
| Mar 31, 2024 | -41.92 Mn |
| Dec 31, 2023 | 16.36 Mn |
| Sep 30, 2023 | -7.29 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | -107.40 Mn |
| Jun 30, 2022 | 16.49 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2020 | -498,000.00 |
| Mar 31, 2020 | -995,000.00 |
| Dec 31, 2019 | 187,000.00 |